TL;DR
This study uses a Mendelian randomization approach to investigate the causal link between plasma polyunsaturated fatty acids (PUFAs) and female reproductive longevity. They found that higher levels of docosahexaenoic acid (DHA), a type of omega-3 PUFA, are causally associated with a delayed age of natural menopause, suggesting DHA as a potential target for extending reproductive lifespan.
What Problem Does This Paper Address?
Female reproductive longevity, defined by the age of menarche and menopause, has remained relatively consistent despite significant increases in overall human life expectancy. This discrepancy is thought to be due to evolutionary adaptations not keeping pace with rapid environmental and lifestyle changes, such as increased chemical pollution and nutritional imbalances. Given the trend of delayed childbearing, identifying factors that can extend the fertile window is crucial. Polyunsaturated fatty acids (PUFAs), particularly omega-3 and omega-6, are bioactive lipid mediators with known roles in human health, and imbalances in their intake have raised concerns about reproductive health. While some studies have explored the link between PUFAs and ovarian reserve, findings have been inconsistent, and many studies suffer from limitations like confounding biases and small sample sizes. This paper aims to address this gap by investigating the causal relationships between specific plasma PUFAs and female reproductive lifespan across different ancestries using a robust methodology.
Methods
The study employed a three-stage Mendelian randomization (MR) framework: discovery, replication, and cross-ancestry analyses. MR is a powerful technique that uses genetic variants as instrumental variables (IVs) to infer causal relationships, mimicking randomized controlled trials and reducing confounding bias.
The core MR assumptions were addressed:
- Strong association with exposure: Instrumental variants (SNPs) were selected based on genome-wide association study (GWAS) data for plasma PUFA concentrations, with stringent statistical thresholds and linkage disequilibrium (LD) clumping to ensure independence.
- Independence from confounders: Known confounders for female fertility (smoking, alcohol, BMI, oral contraceptive use, family history of premature ovarian insufficiency, childbearing history) were assessed, and SNPs associated with these confounders were excluded.
- No horizontal pleiotropy: SNPs affecting the outcome only through the exposure were ensured. This was tested using various sensitivity analyses, including MR-Egger regression, weighted median, and MR-PRESSO, to detect and account for pleiotropic effects.
The study also conducted specific analyses:
- FADS region analysis: The FADS gene cluster plays a crucial role in PUFA metabolism. The study analyzed MR estimates both with and without SNPs in the FADS region to assess the influence of this pathway and identify independent effects of specific PUFAs.
- Cross-ancestry analysis: To ensure generalizability, the study examined the associations in both European and East Asian populations.
- Meta-analyses: Results from discovery and replication phases were combined to strengthen the evidence.
Datasets
The study utilized summary statistics from large-scale genome-wide association studies (GWASs):
- Exposure Data (Plasma PUFA Concentrations):
- UK Biobank (UKB): European individuals (n > 114,999) for plasma total omega-3, total omega-6, DHA, and LA.
- CHARGE consortium: European individuals (n = 7596-8896) for plasma ALA, DPA, EPA, AA, DGLA, and GLA.
- Singapore Chinese Health Study (SCHS): East Asian individuals (n = 1316) for plasma DHA, EPA, ALA, LA, DGLA, and AA.
- Finnish individuals (n = 13,544) for replication analysis.
- Outcome Data (Reproductive Longevity):
- Reproductive Genetics Consortium (ReproGen): European females for age at menarche (AAM) (n = 329,345) and age at natural menopause (ANM) (n = 202,323).
- National Bioscience Database Center (NBDC) Human Database (Japan): East Asian females for AAM (n = 43,861) and ANM (n = 67,029).
Key Insights and Ideas
- DHA as a potential longevity factor: The most striking finding is the consistent evidence for DHA's causal role in delaying natural menopause. This suggests that higher DHA levels may contribute to a longer reproductive lifespan.
- Specificity of PUFA effects: Not all PUFAs showed significant associations. The study highlights that specific omega-3 fatty acids, particularly DHA, are more influential on reproductive longevity than others.
- FADS region's influence: The FADS gene cluster's role in PUFA metabolism is significant. Analyzing results with and without FADS-related SNPs helped disentangle the independent effects of DHA from broader PUFA pathway influences.
- No impact on menarche: Interestingly, none of the PUFAs examined showed a significant causal effect on the age of menarche. This is a crucial finding, as it suggests that interventions targeting reproductive longevity via PUFAs might not interfere with sexual maturation.
- Cross-ancestry consistency: The findings for DHA's effect on ANM were largely consistent between European and East Asian populations, reinforcing the robustness of the results, although statistical power differed.
Key Results
- A one standard deviation (SD) increase in standardized plasma DHA was associated with a 0.178-year delay in ANM (p = 1.1 × 10−4) in discovery analyses.
- This effect was replicated and strengthened in subsequent analyses, with a 0.264-year increase in ANM for a 1 SD increase in plasma DHA (p = 1.5 × 10−3).
- Total omega-3 also showed a significant association with delaying ANM (0.218-year delay per SD increase, p = 4.6 × 10−5).
- Alpha-linolenic acid (ALA), another omega-3, showed a trend towards earlier menopause (0.182-year earlier per SD increase, p = 1.1 × 10−4).
- In East Asian populations, a 1 SD increase in plasma DHA was associated with a 0.303-year delay in ANM (p = 0.049), considered suggestively associated.
- No significant associations were found between any of the studied PUFAs and age at menarche (AAM) in either discovery or replication analyses.
- Sensitivity analyses, including the exclusion of FADS-related SNPs and SNPs associated with other fatty acids, consistently supported the protective effect of DHA on ANM.
Limitations and Future Work
The authors acknowledge several limitations:
- Overlapping samples: Potential type I errors and sample bias due to overlapping samples between large GWAS databases (UKB and ReproGen). A replication study with a non-overlapping dataset was performed to mitigate this.
- Relaxed p-value thresholds: In the East Asian SCHS GWAS, relaxed p-value thresholds were used for some SNPs, though F-statistics indicated no weak instrument bias.
- Sex-specific data: PUFA data were measured in both sexes, but outcome data were female-specific. While GWAS data were sex-adjusted, the lack of female-specific metabolite GWASs is a limitation.
- Further validation needed: While MR provides robust causal inferences, the authors recommend further validation through randomized controlled trials (RCTs).
Future work could focus on:
- Mechanisms of action: Investigating how DHA's anti-inflammatory properties might combat ovarian aging.
- Optimal supplementation strategies: Exploring specific DHA dosages and formulations for extending reproductive longevity.
- Broader population studies: Expanding cross-ancestry analyses to include more diverse populations to capture potential genetic variations in PUFA metabolism and reproductive aging.
Summary updated